Acadian Asset Management LLC Cytom X Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,100,994 shares of CTMX stock, worth $3.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,100,994
Previous 2,728,569
13.65%
Holding current value
$3.38 Million
Previous $3.32 Million
9.96%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding CTMX
# of Institutions
71Shares Held
50.7MCall Options Held
112KPut Options Held
8.3K-
Tang Capital Management LLC San Diego, CA7.81MShares$8.51 Million0.79% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$5.7 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$5.63 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.81MShares$5.24 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.02MShares$3.29 Million0.96% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $71.9M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...